Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous nitroglycerin and dobutamine infusion for occult hypoperfusion during anesthesia
IRCT2015011815774N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nitroglycerin and dobutamine in occult hypoperfusion (OH) and metabolic acidosis, sponsored by Iran University of Medical Sciences. Started Jan 2013; status: completed.
02
Drugs
nitroglycerindobutamine
03
Conditions
occult hypoperfusion (OH)metabolic acidosis
Beyond the preview
Go deeper on IRCT2015011815774N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015011815774N2.